Unadjusted model | Final model (R2=0.108, p=0.004) | |||
β-coefficient (95% CI) | p-value | β-coefficient (95% CI) | p-value | |
Age yrs | 0.395 (0.085–0.704) | 0.013 | 0.330 (0.022–0.639) | 0.036 |
Sex | 0.108 (-9.486–9.702) | 0.982 | ||
BMI kg·m−2 | 0.937 (0.238–1.635) | 0.009 | 0.801 (0.102–1.499) | 0.025 |
Total SFA mg·L−1 | 0.017 (-0.002–0.036) | 0.075 | ||
Total MUFA mg·L−1 | 0.016 (-0.001–−0.032) | 0.062 | ||
Total PUFA mg·L−1 | 0.003 (-0.014–0.019) | 0.760 | ||
ICS dose# μg·day−1 | 0.003 (-0.002–0.009) | 0.235 | ||
Use of ICS treatment yes/no | 4.831 (-4.515–14.177) | 0.308 |
BMI: body mass index; SFA: saturated fatty acids; MUFA: monounsaturated fatty acids; PUFA: polyunsaturated fatty acids; ICS: inhaled corticosteroid. #: beclomethasone equivalents.